» Articles » PMID: 28684940

Management of Intestinal Failure: The High-Output Enterostomy and Enterocutaneous Fistula

Overview
Date 2017 Jul 8
PMID 28684940
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

This article provides an overview of the pathophysiology, causes, investigations, and management of high-output enterostomy and enterocutaneous fistula. High-output stoma and enterocutaneous fistula can result in intestinal failure and this is often fatal if not managed properly. The management involves reducing fluid losses, providing nutrients with fluids, and treating the underlying cause and sepsis. A multidisciplinary approach is required for successful management of patients with high-output enterostomy and enterocutaneous fistula.

Citing Articles

A review of platelet-rich plasma for enteric fistula management.

Liang S, Zheng Z, Li Y, Yang Y, Qin L, Zhao Z Front Bioeng Biotechnol. 2023; 11:1287890.

PMID: 38033816 PMC: 10685294. DOI: 10.3389/fbioe.2023.1287890.


Preoperative Hemoglobin Level as Predictor of the Development of High-output Stoma in Rectal Cancer Surgery.

Kawazoe T, Ohgaki K, Fujinaka Y, Wang H, Morita K, Nakanishi R Cancer Diagn Progn. 2023; 3(6):667-672.

PMID: 37927812 PMC: 10619571. DOI: 10.21873/cdp.10270.


Effect of Thickening Powder on Gastrointestinal Losses in Patients With High-output End Jejunostomy Syndrome - Preliminary Results.

Zaczek Z, Dabrowska K, Omidi M, Panczyk M, Sobocki J In Vivo. 2022; 36(2):884-889.

PMID: 35241546 PMC: 8931876. DOI: 10.21873/invivo.12777.


Management of Enterocutaneous Fistula: A Review.

Ghimire P JNMA J Nepal Med Assoc. 2022; 60(245):93-100.

PMID: 35199684 PMC: 9157672. DOI: 10.31729/jnma.5780.


Risk factors for developing high-output ileostomy in CRC patients: a retrospective study.

Bai D, Li L, Shen Z, Huang T, Wang Q, Wang Y BMC Surg. 2021; 21(1):300.

PMID: 34174862 PMC: 8235810. DOI: 10.1186/s12893-021-01288-y.


References
1.
Farthing M . Octreotide in dumping and short bowel syndromes. Digestion. 1993; 54 Suppl 1:47-52. DOI: 10.1159/000201077. View

2.
Scott N, Leinhardt D, OHanrahan T, Finnegan S, Shaffer J, Irving M . Spectrum of intestinal failure in a specialised unit. Lancet. 1991; 337(8739):471-3. DOI: 10.1016/0140-6736(91)93403-v. View

3.
Jeppesen P . Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome. Therap Adv Gastroenterol. 2012; 5(3):159-71. PMC: 3342570. DOI: 10.1177/1756283X11436318. View

4.
Nightingale J, Lennard-Jones J, Walker E, Farthing M . Jejunal efflux in short bowel syndrome. Lancet. 1990; 336(8718):765-8. DOI: 10.1016/0140-6736(90)93238-k. View

5.
Reber H, Roberts C, Way L, Dunphy J . Management of external gastrointestinal fistulas. Ann Surg. 1978; 188(4):460-7. PMC: 1396834. DOI: 10.1097/00000658-197810000-00003. View